ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "body composition"

  • Abstract Number: 2501 • ACR Convergence 2025

    Microvascular dysfunction contributes to hand bone deterioration in SSc patients

    Rosanna Campitiello1, Sabrina Paolino2, Andrea Casabella3, Giulia Davoli2, Elisa Caratto4, Emanuele Gotelli1, Elvis Hysa5, Carmen Pizzorni2, Vanessa Smith6, Alberto Sulli2 and Maurizio Cutolo7, 1University of Genoa, Genoa, Liguria, Italy, 2University of Genoa, Genova, Italy, 3IRCCS Ospedale Policlinico San Martino, Genova, Italy, 4Univeristy of Genoa, Alessandria, Italy, 5University of Genoa, Genoa, Italy, 6Ghent University Hospital, Gent, Belgium, 7University of Genova, Genova, Italy

    Background/Purpose: Systemic sclerosis (SSc) is a rare autoimmune disease characterized by endothelial dysfunction, self-reactive immune response and progressive systemic fibrosis1. It is well established that…
  • Abstract Number: 2340 • ACR Convergence 2025

    Lighten the Load: Artificial Intelligence Reveals Body Mass Index Outranks Treatment in One-Year Psoriatic Arthritis Outcomes—Findings from the SPEED Trial

    Alexander Garaiman1, Sophia Massa1, Elnaz Saeedi2, Nicola Gullick3, William Tillett4, Raphaël Hurtubise1, jean-guillaume letarouilly5 and Laura Coates6, 1Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK., Oxford, United Kingdom, 2Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK., Oxford, 3Rheumatology Department, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK, Coventry, United Kingdom, 4Department of Life Sciences, Centre for Therapeutic Innovation, University of Bath, Bath, United Kingdom, 5Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK, Oxford, United Kingdom, 6Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, England, United Kingdom

    Background/Purpose: Personalizing care in early psoriatic arthritis (PsA) is challenging. We set out to identify predictors of one-year response on the PASDAS using AI-based methods…
  • Abstract Number: 1885 • ACR Convergence 2025

    Sex-specific Associations of Anthropometrics, Smoking and Eduction with the Risk of Rheumatoid Athritis: A Nested Case-Control Study

    Carl Turesson1, Linnea arvidsson2, Emil Rydell1 and Ulf Bergström3, 1Lund University, Malmö, Sweden, 2Lund University, Malmö, 3Lund University, Malmö, Sweden

    Background/Purpose: Smoking is an established risk factor for rheumatoid arthritis (RA), and there is also evidence for an association with socioeconomic factors. As RA is…
  • Abstract Number: 1557 • ACR Convergence 2025

    Association between Thoracic Muscle and Fat Area and Density and Pulmonary Function in Systemic Sclerosis

    Aradhna Agarwal1, Niki Pradhan1, James St. Clair2, Dinesh Khanna3 and Elana Bernstein4, 1Columbia University Medical Center, New York, NY, 2University of Michigan, Ann Arbor, 3University of Michigan, Ann Arbor, MI, 4Columbia University, New York, NY

    Background/Purpose: Interstitial lung disease (ILD) is the leading cause of mortality in systemic sclerosis (SSc). Little is known about the association between body composition and…
  • Abstract Number: 1383 • ACR Convergence 2025

    Obesity in Primary Sjogren’s Disease

    Gabriela Hernandez-Molina1, Donaji Gómez-Velasco2, Ariel Garcia-Torralba2, Carlos Aguilar-Salinas2 and Ivette Cruz-Bautista2, 1Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Federal District, Mexico, 2Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

    Background/Purpose: Obesity is an excessive fat accumulation that presents a risk to health. Little is known about the relationship between obesity and Sjögren’s disease (SjD).…
  • Abstract Number: 0635 • ACR Convergence 2025

    Comparison of the SARC-F with Objective Measures of Sarcopenia in Women with Systemic Lupus Erythematosus

    Sarah Lieber1, Neha Nagpal1, Julia Nguyen2, Ashley Chung2, Dongmei Sun1, John Carrino3, M. Carrington Reid4 and Lisa Mandl1, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, New York, 3Department of Radiology and Imaging, Hospital for Special Surgery, New York, NY, 4Weill Cornell Medicine, New York, NY

    Background/Purpose: Sarcopenia, i.e., loss of skeletal muscle mass and strength, has been associated with multiple adverse health outcomes, including mortality. We have previously demonstrated associations…
  • Abstract Number: 0388 • ACR Convergence 2024

    The Association Between Body Composition and Disease and Treatment Outcomes in Patients with Juvenile Idiopathic Arthritis: Results from the CAPRI Registry

    Samantha Morin1, KAREN BEATTIE2, Roxana Bolaria3, Tania Cellucci4, Gaelle Chedeville5, Amieleena Chhabra6, Paul Dancey7, Tommy Gerschman8, Liane Heale9, Julie Herrington2, Adam Huber10, Mehul Jariwala11, Jean-Philippe Proulx-Gauthier12, Dax Rumsey13, Heinrike Schmeling14, Jaime Guzman15 and Michelle Batthish4, and CAPRI Registry Investigators, 1McMaster University, Hamilton, Canada, 2McMaster University, Hamilton, ON, Canada, 3Victoria Arthritis Center, Victoria, BC, Canada, 4McMaster Children's Hospital, Hamilton, ON, Canada, 5The Montreal Children's Hospital, Montreal, QC, Canada, 6University of British Columbia, Penticton, BC, Canada, 7Memorial University, St. John's, Canada, 8University of British Columbia - Vancouver, North Vancouver, BC, Canada, 9McMaster University, Oakville, ON, Canada, 10IWK Health Centre, Halifax, NS, Canada, 11Jim Pattison Children's Hospital, Saskatoon, Canada, 12CHU de Quebec - Universite Laval, Quebec, QC, Canada, 13University of Alberta, Edmonton, AB, Canada, 14University of Calgary, Calgary, AB, Canada, 15University of British Columbia and BC Children's Hospital, Vancouver, BC, Canada

    Background/Purpose: Recent evidence has linked abnormal body weight, underweight or obesity, with poor disease outcomes in adults with inflammatory arthritis. Yet, little is known about…
  • Abstract Number: 0560 • ACR Convergence 2024

    Association Between a Self-Report Screening Tool for Sarcopenia (SARC-F) and Disease Activity, Muscle Strength and Muscle Power Measures, Patient-Reported Outcomes and Body Composition in Patients with Spondyloarthritides

    Iuliia Kononenko1, Marius Bedei2, Bjoern Buehring3, Xenofon Baraliakos4 and Uta Kiltz5, 1Rheumazentrum Ruhrgebiet Herne, Ruhr University Bochum, Germany, Bochum, Germany, 2Rheumazentrum Ruhrgebiet Herne, Ruhr University Bochum, Germany, Herne, Germany, 3Bergisches Rheuma-Zentrum, Wuppertal, Germany, 4Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 5Rheumazentrum Ruhrgebiet Herne, Ruhr-University, D-44649 Herne, Germany

    Background/Purpose: The SARC-F is a self-report screening tool for sarcopenia (Sar) used to identify individuals at risk for poor functional outcomes [1]. The aim of this study was…
  • Abstract Number: 0598 • ACR Convergence 2024

    Cardio-metabolic Effects of Apremilast in Patients with Psoriatic Arthritis: A Prospective Cohort Study

    Eva van Geel1, Romy Hansildaar2, Fatih Çoban1, Bas Dijkshoorn1, Maaike Heslinga1, Reinhard Bos3, Mies Korteweg1, Arno Van Kuijk1 and Michael Nurmohamed4, 1Amsterdam Rheumatology and immunology Center, Amsterdam, Netherlands, 2Amsterdam Rheumatology and immunology Center location Reade, Amsterdam, Netherlands, 3Medical Center Leeuwarden, Leeuwarden, Netherlands, 4Reade and Amsterdam UMC, Kortenhoef, Netherlands

    Background/Purpose: Psoriatic arthritis (PsA) is associated with metabolic and cardiovascular disease. Studies have suggested that treatment with apremilast is associated with weight loss and other…
  • Abstract Number: 0992 • ACR Convergence 2024

    Visceral Adipose Tissue Measured by DXA Predicts Metabolic Syndrome in Low-Income Community-Dwelling Elderly: Insights from the São Paulo Ageing & Health (SPAH) Study

    Gabriel Vansuita Valente1, Luana Machado1, Andre Franco2, Valeria Caparbo1, Liliam Takayama3, Alan Lins Fernandes1, Camille Figueiredo1, Rosa M R Pereira1 and Diogo Domiciano2, 1Division of Rheumatology, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR., São Paulo, SP, Brazil, 2Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, São Paulo, SP, Brazil, 3Division of Rheumatology, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, São Paulo, SP, Brazil

    Background/Purpose: To establish optimal cutoffs for visceral adipose tissue (VAT) to predict cardiometabolic risk in a low-income elderly Brazilian cohort, utilizing dual-energy X-ray absorptiometry (DXA)…
  • Abstract Number: 1192 • ACR Convergence 2024

    Relationship Between Measures of Fat Mass and Knee Osteoarthritis Incidence: The Multicenter Osteoarthritis (MOST) Study

    Kristine Godziuk1, Sarah Tilley2, mike LaValley3, Douglas Kiel4, Michael Nevitt5, C.E. Lewis6, James Torner7 and Tuhina Neogi2, 1University of Alberta, Edmonton, AB, Canada, 2Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 3Boston University School of Public Health, Arlington, MA, 4Hebrew SeniorLife and Department of Medicine Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, 5UCSF, Orinda, CA, 6University of Alabama at Birmingham, Birmingham, AL, 7University of Iowa, Iowa City

    Background/Purpose: Obesity [defined by body mass index (BMI) ≥30 kg/m2] is an established risk factor for incident radiographic knee OA (ROA). However, the relative contributions…
  • Abstract Number: 1348 • ACR Convergence 2024

    Analysis of Body Composition in Patients with Moderate-Severe Rheumatoid Arthritis Treated with Anti-TNF Drugs

    Aimara García-Studer1, Fernando Ortiz-Márquez1, Paula Borregón-Garrido1, Arkaitz Mucientes-Ruiz1, Sara Manrique-Arija1 and Natalia Mena Vázquez2, 1Biomedical Research Institute of Malaga (IBIMA)-Bionand Platform, Department of Rheumatology, Regional University Hospital of Malaga, Malaga, Spain, 2IBIMA, Málaga, Andalucia, Spain

    Background/Purpose: Previous studies have described alterations in fat and lean mass in patients with RA, but the effect of treatments on body composition remains unclear.…
  • Abstract Number: 2070 • ACR Convergence 2024

    Increased Circulating Levels of Fatty Acid-binding Proteins as a Potential Biomarker of Disease Damage in Inflammatory Myopathies Patients

    Margherita Giannini1, Anne-Laure Charles2, Julien Blaess3, Rose-Marie Javier4, Bernard Geny5 and Alain Meyer6, 1UR3072, Physiology Department, University Hospital of Strasbourg, Strasbourg, France, 2UR3072, University of Strasbourg, Strasbourg, France, 3Physiology Department, University Hospital of Strasbourg, STRASBOURG, France, 4Rheumatology Department, University Hospital of Strasbourg, STRASBOURG, France, 5UR3072, Physiology Department, University Hospital of StrasbourgUniversity Hospital of Strasbourg, STRASBOURG, France, 6UR3072, Physiology Department, Rheumatology Department, University Hospital of Strasbourg, Strasbourg, France

    Background/Purpose: In inflammatory myopathies (IM), although several treatments effectively control disease activity, a high proportion of patients display sustained disability (damage). Damage might be reversed…
  • Abstract Number: 0294 • ACR Convergence 2023

    Tofacitinib Treatment in Rheumatoid Arthritis Is Associated with Increased Lower Limb Muscle Volume: The Rheumatoid Arthritis and Muscle (RAMUS) Study

    Joshua L Bennett1, Kieren G Hollingsworth2, Arthur Pratt3, Maha Egail3, Catherine Feeney4, Valeria Di Leo4, Robert W Taylor4, Richard Dodds5, Amy E Anderson3, Avan Aihie Sayer5 and John Isaacs6, 1Immunity and Inflammation Theme, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle upon Tyne, United Kingdom, 2Innovation Methodology and Application Theme, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom, 3Immunity and Inflammation Theme, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom, 4Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom, 5AGE Research Group, NIHR Newcastle Biomedical Research Centre, Newcastle Hospitals NHS Foundation Trust and Newcastle University, Newcastle upon Tyne, United Kingdom, 6Translational and Clinical Research Institute, Newcastle University and Musculoskeletal Unit, Newcastle Hospitals, Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom

    Background/Purpose: Approximately 1 in 4 people with RA have sarcopenia, defined as generalised loss of skeletal muscle (SKM) strength and mass, resulting in an increased…
  • Abstract Number: 0334 • ACR Convergence 2023

    Association of a Self-Report Screening Tool for Sarcopenia (SARC-F) with Functional Status Outcomes in Systemic Lupus Erythematosus

    Sarah Lieber1, Yvonne Shea2, Deanna Jannat-Khah2, John Carrino2, M. Carrington Reid3 and Lisa Mandl1, 1Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 2Hospital for Special Surgery, New York, NY, 3Weill Cornell Medicine, New York, NY

    Background/Purpose: Sarcopenia, i.e., loss of skeletal muscle mass and strength, has been associated with multiple adverse health outcomes, including mortality. Although limited data suggest that…
  • 1
  • 2
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology